Skip to main content

Animations

MJFF Publications

4601 - 4610 of 6403 Results
Title
Year
  • Year
  • 2018
  • 2023
  • 2022
  • 2025
  • 2021
  • 2022
  • 2020
  • 2021
  • 2018
  • 2020
  • Summary Details
    OPEN
    Title: Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI Study
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2018.00045
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissues
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41587-023-01751-6
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Sex Differences in Brain and Cognition in de novo Parkinson's Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.791532
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00884-6
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-021-00427-6
    Citation Count: 341
  • Summary Details
    OPEN
    Title: Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-022-00520-4
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28206
    Citation Count: 156
  • Summary Details
    OPEN
    Title: Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD Samples
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.704041
    Citation Count: 23
  • Summary Details
    OPEN
    Title: The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1100-1
    Citation Count: 148
  • Summary Details
    OPEN
    Title: Human plasma biomarker responses to inhalational general anaesthesia without surgery
    Journal Name: British Journal of Anaesthesia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bja.2020.04.085
    Citation Count: 40
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.